Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression (2024) Rabl M, Zullo L, Lewczuk P, Kornhuber J, Karikari TK, Blennow K, Zetterberg H, et al. Journal article The effects of exercise programs on cognition, activities of daily living, and neuropsychiatric symptoms in community-dwelling people with dementia-a systematic review (2022) Steichele K, Keefer A, Dietzel N, Grässel E, Prokosch HU, Kolominsky-Rabas P Journal article, Review article Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes (2022) Lampe L, Niehaus S, Huppertz HJ, Merola A, Reinelt J, Mueller K, Anderl-Straub S, et al. Journal article A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro (2022) Aillaud I, Kaniyappan S, Chandupatla RR, Ramirez LM, Alkhashrom S, Eichler J, Horn A, et al. Journal article Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression (2021) Clark C, Lewczuk P, Kornhuber J, Richiardi J, Maréchal B, Karikari TK, Blennow K, et al. Journal article Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease (2019) Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P Journal article, Review article Impact of a clinical decision support tool on prediction of progression in early-stage dementia: A prospective validation study (2019) Bruun M, Frederiksen KS, Rhodius-Meester HFM, Baroni M, Gjerum L, Koikkalainen J, Urhemaa T, et al. Journal article Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease (2019) Baldeiras I, Santana I, Leitao MJ, Vieira D, Duro D, Mroczko B, Kornhuber J, Lewczuk P Journal article White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation (2018) Teunissen CE, Otto M, Engelborghs S, Herukka SK, Lehmann S, Lewczuk P, Lleo A, et al. Journal article Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease (2018) Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P, Maler JM, et al. Journal article